Alexander’s(ALX)

Search documents
Three Office REITs To Sell With Weak Balance Sheets
Seeking Alpha· 2024-06-27 12:00
holicow/E+ via Getty Images If you have read my recent articles, you know that I am expecting a major sell-off in REITs over the next 2 - 5 years. As the graph below shows, the REIT rally that began in October, fueled by expectations of multiple rate cuts by the Fed, is showing signs of fizzling out. VNQ price chart (Seeking Alpha Premium) This is a 180-degree about-face from my outlook at the beginning of this year. I base this new expectation primarily on the technicals, but also on a looming crisi ...
ALX Oncology: Finally Reaching A Reasonable Buy-In Valuation
Seeking Alpha· 2024-06-27 08:13
DNY59 Topline Summary and Update ALX Oncology (NASDAQ:ALXO) is a cancer-focused biotech I've expressed deep skepticism in over the course of various articles, stating unequivocally that I did not feel that the risk to reward ratio was appropriate at the billion-plus market cap that the company was commanding as a phase 2 entity. They had generated compelling findings in their early trial readouts, but the CD47-based approach carries too much baggage for me to get too excited. Since then, the company's va ...
ALX Resources Corp. Receives Analytical Results from the Gibbons Creek Uranium Project, Athabasca Basin, Saskatchewan
Newsfile· 2024-06-13 11:30
ALX Resources Corp. Receives Analytical Results from the Gibbons Creek Uranium Project, Athabasca Basin, SaskatchewanJune 13, 2024 7:30 AM EDT | Source: ALX Resources Corp.Vancouver, British Columbia--(Newsfile Corp. - June 13, 2024) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce the results of the 2024 winter drilling program and upcoming summer 2024 exploration plans at its Gibbons Creek Uranium Project ("Gibbons Creek", or the "Proj ...
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
globenewswire.com· 2024-05-29 13:00
SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that management will participate in the Jefferies Global Healthcare Conference. Details are as follows: Format: Fireside chat with analyst, Michael Yee and 1x1 Investor MeetingsDate: Wednesday, June 5, 2024 Time: 1:00 PM ET Location: New York, NY Webcast link: ...
The Ultimate Contrarian Plays: 7 Hated Stocks Yielding Up To 12.9%
forbes.com· 2024-05-19 14:30
People walk by the New York Stock Exchange building in the financial district on Wall Street in ... [+] lower Manhattan New York USA is home to one of the world's leading financial marketsgettyWhat’s better than a big dividend?A hated high yield.Especially when the disgust comes from Wall Street analysts themselves. You know, the fanboys who follow the company for a living.Analysts are paid to be bullish. Let’s face it, nobody wants to hear from a bear.There are just two consensus Sell calls across the enti ...
Alexander's (ALX) Misses Q1 FFO and Revenue Estimates
Zacks Investment Research· 2024-05-06 14:41
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $4.98 per share, missing the Zacks Consensus Estimate of $6.41 per share. This compares to FFO of $3.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of -22.31%. A quarter ago, it was expected that this real estate investment trust would post FFO of $5.95 per share when it actually produced FFO of $4.99, delivering a surprise of -16.13%.Over the last four quart ...
Alexander's Announces First Quarter Financial Results
Newsfilter· 2024-05-06 12:51
Core Insights - Alexander's, Inc. reported a net income of $16.1 million, or $3.14 per diluted share, for the quarter ended March 31, 2024, an increase from $11.2 million, or $2.19 per diluted share, for the same quarter in 2023 [1][3] - Funds from operations (FFO) for the quarter was $25.5 million, or $4.98 per diluted share, compared to $18.6 million, or $3.63 per diluted share, for the quarter ended March 31, 2023 [1][3] - The company operates as a real estate investment trust (REIT) with five properties located in New York City [1] Financial Performance - Revenues for the quarter ended March 31, 2024, were $61.4 million, up from $52.9 million in the same quarter of 2023 [3][4] - The weighted average shares outstanding for basic and diluted calculations were 5,130,678 for both 2024 and 2023 [3][4] - Depreciation and amortization of real property for the quarter was $9.4 million, compared to $7.4 million in the previous year [4]
Alexander’s(ALX) - 2024 Q1 - Quarterly Report
2024-05-06 12:28
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark one) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission File Number: 001-06064 ALEXANDERS INC (Exact name of registrant as specified in its charter) Delaware 51-0100517 | --- | --- | |-------------- ...
Alexander's, Inc. Extends Bloomberg LP's Global Headquarters Lease at 731 Lexington Avenue Tower Through 2040
Newsfilter· 2024-05-06 12:05
NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. today announced an 11-year lease extension agreement with Bloomberg LP which will begin at the expiration of the existing lease in 2029, continuing a long-standing headquarters presence at 731 Lexington Avenue through 2040. Bloomberg, which relocated its global headquarters to the tower upon its completion, will continue to occupy all 946,815 square feet of office space in the building. The company's headquarters at 731 Lexington remains its large ...
Alexander's Announces First Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
Newsfilter· 2024-04-25 16:20
PARAMUS, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE:ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended March 31, 2024 with the U.S. Securities and Exchange Commission and issue its first quarter earnings release on Monday, May 6, 2024, before the New York Stock Exchange opens. Vornado Realty Trust (NYSE:VNO), the manager which conducts Alexander's operations, announced it will host its quarterly earnings conference call and an audio webcast o ...